HOME >> MEDICINE >> NEWS
Combined molecular-targeted and hormonal therapies offer promise in treating ovarian cancer

Houston May 08, 2007 -- A combination of molecular-targeted therapy and hormonal therapy may be the most promising area of research for those seeking an effective treatment for ovarian cancer, according to a new review in the International Journal of Gynecological Cancer.

"Several clinical trials have confirmed the role of hormone therapy in recurrent ovarian cancer treatment, especially in patients with low-grade tumors," says review author Dr. Siqing Fu, an assistant professor of oncology at the University of Texas at Houston. "However, more research is needed to determine whether combining molecular-targeted therapy with hormonal therapy would be a more effective option."

Ovarian cancer is the deadliest of gynecological cancers; approximately 70 percent of patients are diagnosed in the later stages, when the 5-year survival rate drops below 25 percent. Traditional chemotherapy has proven to be generally ineffective against recurrent ovarian cancer, which has led researchers to investigate novel treatments.

"While a cure is unlikely, the goals of treatment are to control tumor-related symptoms and to improve or maintain quality of life," says Dr. Fu. "After surveying the latest research, combined molecular-targeted and hormonal therapy offers the greatest promise in achieving these goals and therefore deserves further investigation."


'"/>

Contact: Sean Wagner
swagner@bos.blackwellpublishing.com
781-388-8550
Blackwell Publishing Ltd.
8-May-2007


Page: 1

Related medicine news :

1. Combined imaging approach may provide better identification of difficult-to-diagnose brain clots
2. Combined therapies may boost immune response and long-term protection against brain tumors
3. Combined liver-kidney transplant beneficial for patients with dual organ disease
4. Combined contrast enhanced MRI shows promise
5. Combined treatment cuts inflammatory cells in chronic obstructive pulmonary disease
6. Combined MRI and mammography more effective at detecting breast cancer in high-risk women
7. Nonhormonal drug reduces hot flashes in men treated for prostate cancer
8. Bulimia may result from hormonal imbalance
9. 1 in 5 early-stage breast cancer patients may not follow hormonal therapy plan
10. Genomic tests improve prediction of breast cancer response to chemotherapy, hormonal therapy
11. Some nonhormonal therapies may offer relief from hot flashes, but with possible adverse effects

Post Your Comments:
(Date:4/24/2015)... AK (PRWEB) April 24, 2015 As ... (#MOTMC2015) and the unique sacrifices of these young men ... for Service members, Veterans and their Families” presents a ... training is designed to gain a better understanding of ... health and wellness. For those – civilian and military ...
(Date:4/24/2015)... New York, New York (PRWEB) April 24, 2015 ... continue to move forward in the federal ... of South Carolina. According to court documents, the ... Status Report on April 16th detailing, among other ... The report notes that counsel for both plaintiffs ...
(Date:4/24/2015)... Lowcostcarinsuranceprice.com has released a new blog post ... for senior citizens . , Senior citizens may ... mean that they cannot find affordable coverage. By comparing ... the right coverage for their cars at the best ... http://lowcostcarinsuranceprice.com/ provides free leads from various agencies that ...
(Date:4/24/2015)... Vancouver, BC (PRWEB) April 24, 2015 ... Albert Yuzpe, Olive Fertility co-founder and co-director, has been ... Fertility Preservation at the Evening of Hope Gala. ... to recognize Dr. Albert Yuzpe, who has been at ... past 43 years,” says Jessica Séguin, Executive Director of ...
(Date:4/24/2015)... ON (PRWEB) April 24, 2015 ... safe, informed and legal access to medical cannabis, is ... are properly supported when advising patients. , NAC is ... Certificate Program. With a $250,000 grant, NAC will be ... program. , "Our goal is to help Canadians gain ...
Breaking Medicine News(10 mins):Health News:Coalition Presents Resiliency Training to Raise Awareness during Month of the Military Child (#MOTMC2015) 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 3Health News:Low Cost Auto Insurance Quotes for Senior Citizens 2Health News:Olive Fertility Centre Co-founder, Dr Al Yuzpe, Recognized as a Pioneer in Fertility Preservation 2Health News:National Access Cannabis Gives 300 Canadian Healthcare Professionals Access to Medical Cannabis Certificate Program 2
(Date:4/24/2015)... 24, 2015  Elekta has CE marked the latest ... system , enabling European clinics to deliver a sophisticated ... including advanced 3D planning, IMRT, VMAT and stereotactic planning ... Monaco ® v5.10 provides ... efficiency. Advancements in 3D planning as well as the ...
(Date:4/23/2015)... -- ResMed Inc. (NYSE: RMD ) today announced results ... the quarter was $422.5 million, a 6 percent increase ... 13 percent increase on a constant currency basis).  Net ... compared to the quarter ended March 31, 2014.  Diluted ... increase of 2 percent compared to the quarter ended ...
(Date:4/23/2015)... FRANCISCO , April 23, 2015 Nektar Therapeutics ... the first quarter ended March 31, 2015 on Thursday, April ... Howard Robin , president and chief executive officer, will host ... p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). ... the conference call can be accessed through a link that ...
Breaking Medicine Technology:Elekta CE marks for Monaco v5.10 treatment planning system 2ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 11ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 12ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 13Nektar to Announce Financial Results for the First Quarter 2015 on Thursday, April 30, 2015, After Close of U.S.-Based Financial Markets 2
Cached News: